Expression of TFR-2 in a variety of cells
| Name . | Origin . | MFI . | ||
|---|---|---|---|---|
| G/14C2 . | G/1C11 . | Control . | ||
| HepG2 | Hepatoma | 73 | 69 | 4 |
| CFPAC-1 | Pancreatic carcinoma | 13 | 15 | 5 |
| SW480 | Colon carcinoma | 4 | 18 | 4 |
| KATO III | Stomach carcinoma | 48 | 20 | 3 |
| T47D | Breast carcinoma | 11 | 15 | 3 |
| DU145 | Prostate carcinoma | 67 | 81 | 7 |
| LAN-1 | Neuroblastoma | 58 | 65 | 5 |
| U251 | Glioma | 26 | 10 | 2 |
| K562 | CML | 346 | 69 | 5 |
| NB-4 | AML | 7 | 6 | 6 |
| HL-60 | AML | 3 | 5 | 2 |
| U937 | AML | 3 | 3 | 3 |
| Jurkat | T-ALL | 6 | 4 | 4 |
| YT | NK-ALL | 5 | 2 | 3 |
| NKL | NK-ALL | 5 | 6 | 4 |
| Raji | B lymphoma | 14 | 18 | 8 |
| SKMM-1 | Myeloma | 39 | 15 | 3 |
| RPMI 8226 | Myeloma | 17 | 9 | 7 |
| FF | Amnion | 3 | 2 | 2 |
| HUVEC | Endothelium | 4 | 4 | 4 |
| Name . | Origin . | MFI . | ||
|---|---|---|---|---|
| G/14C2 . | G/1C11 . | Control . | ||
| HepG2 | Hepatoma | 73 | 69 | 4 |
| CFPAC-1 | Pancreatic carcinoma | 13 | 15 | 5 |
| SW480 | Colon carcinoma | 4 | 18 | 4 |
| KATO III | Stomach carcinoma | 48 | 20 | 3 |
| T47D | Breast carcinoma | 11 | 15 | 3 |
| DU145 | Prostate carcinoma | 67 | 81 | 7 |
| LAN-1 | Neuroblastoma | 58 | 65 | 5 |
| U251 | Glioma | 26 | 10 | 2 |
| K562 | CML | 346 | 69 | 5 |
| NB-4 | AML | 7 | 6 | 6 |
| HL-60 | AML | 3 | 5 | 2 |
| U937 | AML | 3 | 3 | 3 |
| Jurkat | T-ALL | 6 | 4 | 4 |
| YT | NK-ALL | 5 | 2 | 3 |
| NKL | NK-ALL | 5 | 6 | 4 |
| Raji | B lymphoma | 14 | 18 | 8 |
| SKMM-1 | Myeloma | 39 | 15 | 3 |
| RPMI 8226 | Myeloma | 17 | 9 | 7 |
| FF | Amnion | 3 | 2 | 2 |
| HUVEC | Endothelium | 4 | 4 | 4 |
FF indicates fetal fibroblast; HUVEC, human umbilical cord endothelial cell; CML, chronic myeloid leukemia; AML, acute myeloid leukemia; and ALL, acute lymphoblastic leukemia.